陆舜, 朱建权. 贝伐单抗联合卡铂加紫杉醇在非小细胞肺癌中的疗效与安全性评价[J]. 循证医学, 2006, 6(4): 211-212. DOI: 10.3969/j.issn.1671-5144.2006.04.006
    引用本文: 陆舜, 朱建权. 贝伐单抗联合卡铂加紫杉醇在非小细胞肺癌中的疗效与安全性评价[J]. 循证医学, 2006, 6(4): 211-212. DOI: 10.3969/j.issn.1671-5144.2006.04.006
    LU Shun, ZHU Jian-quan. Assessment of the Efficacy and Safety of Bevacizumab Plus Carboplatin and Paclitaxel in Patients with Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2006, 6(4): 211-212. DOI: 10.3969/j.issn.1671-5144.2006.04.006
    Citation: LU Shun, ZHU Jian-quan. Assessment of the Efficacy and Safety of Bevacizumab Plus Carboplatin and Paclitaxel in Patients with Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2006, 6(4): 211-212. DOI: 10.3969/j.issn.1671-5144.2006.04.006

    贝伐单抗联合卡铂加紫杉醇在非小细胞肺癌中的疗效与安全性评价

    Assessment of the Efficacy and Safety of Bevacizumab Plus Carboplatin and Paclitaxel in Patients with Non-Small Cell Lung Cancer

    /

    返回文章
    返回